Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Juni 2020 07:00 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)

CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its...
16. Juni 2020 08:00 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health

CARLSBAD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by...
27. Mai 2020 16:05 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
11. Mai 2020 16:01 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
06. Mai 2020 22:59 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Prices Public Offering of Common Stock

CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
06. Mai 2020 16:01 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Commences Public Offering of Common Stock

CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
04. Mai 2020 16:05 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports First Quarter 2020 Results

CARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. ("GenMark" or the "Company") (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing...
04. Mai 2020 16:03 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces Scott Mendel Appointed CEO

CARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
22. April 2020 16:05 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020

CARLSBAD, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
07. April 2020 16:03 ET | Quelle: GenMark Diagnostics, Inc.

GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance

CARLSBAD, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...

Vorherige Seite

Nächste Seite